SCHEMBL8525313

SCHEMBL8525313

C=CCN(CC=C)c1cc(C(=O)C=C)ccc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
EGFR P00533 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
JAK1 P23458 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
THRB P10828 8/20 0.41
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1688845 0.75 C5AR1 (0.38) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL4905776 0.75 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL8525319 0.73 PTPN1 (0.41) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL12939226 0.70 GAA (0.49) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL7619750 0.70 MEN1 (0.49) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL8525317 0.69 XDH (0.39) ALDH1A1SMN1; SMN2KDM4ETDP1MAPT
SCHEMBL20869224 0.68 ALDH5A1 (0.53) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL19632973 0.68 ABCG2 (0.47) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD
SCHEMBL544101 0.68 C5AR1 (0.44) ALDH1A1MEN1KMT2ACYP3A4LMNA
SCHEMBL12647578 0.67 CYP3A4 (0.49) ALDH1A1SMN1; SMN2KDM4ETDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977075-A N-aroylamino acid amides as endothelin inhibitors NOVARTIS AG (CH) 1999-11-02 US disclosed
EP-0821670-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS Novartis AG (CH) 1998-02-04 EP disclosed
WO-1996033170-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS NOVARITS AG (CH) 1996-10-24 WO disclosed